News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Pharmaxis CEO
The Chairman of the Pharmaxis Ltd Board, Mr Denis Hanley advises that the company's Chief Executive Officer Dr Alan Robertson has undergone a medical procedure. Dr Robertson is expected to make a full recovery but will be absent from the office for the next few weeks.
Read full media release - pdf
Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment
Pharmaxis today announced significant headline results for the final stage of its international Phase III trial of Bronchitol (inhaled mannitol) in people with cystic fibrosis.
Read full media release - pdf
Pharmaxis provides FDA resubmission for Aridol US marketing application
Pharmaxis today announced that the U.S. Food and Drug Administration has acknowledged receipt of the resubmission of its New Drug Application for Aridol™ (mannitol inhalation powder).
Read full media release - pdf